Joseph R. Mazzulli, PhD
Assistant Professor at Northwestern University
Location: Chicago, Illinois, United States
Dr. Joe Mazzulli received his BS in neuroscience and biochemistry from the University of Pittsburgh and completed a PhD in neuroscience from the University of Pennsylvania in 2007. For his PhD thesis work, Dr. Mazzulli studied the effects of dopamine oxidation on the aggregation of alpha-synuclein using cellular and pre-clinical models. He then joined the lab of Dimitri Krainc at the neurology department of Massachusetts General Hospital/Harvard Medical School as a post-doctoral fellow, where he examined the role of lysosomes (packages of enzymes that break down waste) in neurodegenerative diseases. He is currently an assistant professor of neurology at Northwestern University Feinberg School of Medicine in Chicago, IL. His laboratory studies how alpha-synuclein misfolding and aggregation (clumping) results in neurodegeneration using midbrain dopamine cultures from post-mortem samples. Dr. Mazzulli is also a co-founder and scientific advisory board member of Lysosomal Therapeutics, Inc, a company that utilizes lysosomal biology to develop treatments for Parkinson's disease and related neurodegenerative disorders.